Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium.

PURPOSE Alkali burning of the rabbit cornea is a well-established model for the study of anterior surface inflammation, neovascularization, and wound-healing processes. 12-hydroxyeicosanoids have been implicated as mediators of such responses. 12(S)-hydroxyeicosatetraenoic acid (12[S]-HETE) is a lipoxygenase-derived arachidonate metabolite and 12(R)-hydroxyeicosatetraenoic acid (12[R]-HETE) is formed by a cytochrome P450 monooxygenase; both give rise to the potent angiogenic factor 12(R)-hydroxyeicosatrienoic acid (12[R]-HETrE). In this study, the authors correlate the pattern of their synthesis in the corneal epithelium with the inflammatory response after alkali injury. METHODS New Zealand albino rabbits were anesthetized and alkali burns created with 10-mm filter paper discs (1 N NaOH for 2 minutes). Corneas were then rinsed; 1 to 7 days later, corneal epithelium was scraped and used to assess 14C-arachidonic acid conversion to 12-HETE and 12-HETrE enantiomers in the presence of NADPH by chiral high-pressure liquid chromatography. The inflammatory response secondary to the alkali burn was quantified through area measurements of reepithelialization and neovascularization. RESULTS Alkali burn induced a time-dependent production of corneal epithelial 12-HETE and 12-HETrE. A marked increase in 12-HETE and 12-HETrE synthesis was evident at day 2 (from 22 +/- 7 to 139 +/- 22 ng/hour) after injury, increasing to 800 +/- 68 ng/hour at day 7. Chiral analysis revealed a time-dependent synthesis of the R and S enantiomers of 12-HETE (24% R, 76% S) and 12-HETrE (72% R, 28% S). Total arachidonate metabolism, as well as the formation of 12(R)-HETrE, correlated with the area of neovascularization (P < 0.01 and P < 0.02, respectively). CONCLUSIONS The results demonstrate that surviving and regenerating epithelium has an increased capacity of synthesizing 12(S)-HETE and 12(R)-HETE and that maximal production of 12(R)-HETrE, a known direct and indirect angiogenic factor, coincides with neovascularization in this model. Thus, the lipoxygenase and cytochrome P450-dependent activities increased in a time-dependent manner, indicating the potential involvement of both pathways in the inflammatory response to alkali burn. The formation of significant quantities of 12(R)-HETE and 12(R)-HETrE is a novel finding in this alkali injury model.

[1]  N. Abraham,et al.  A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. , 1995, Investigative ophthalmology & visual science.

[2]  N. Abraham,et al.  Activation of nuclear factor kappa B and oncogene expression by 12(R)-hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cells. , 1994, The Journal of biological chemistry.

[3]  H. Jacob,et al.  Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Yamamoto,et al.  Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomes. , 1994, Biochimica et biophysica acta.

[5]  H. Bazan,et al.  Platelet-activating factor induces collagenase expression in corneal epithelial cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Edelhauser,et al.  Swelling in the isolated perfused cornea induced by 12(R)hydroxyeicosatetraenoic acid. , 1993, Investigative ophthalmology & visual science.

[7]  Y. H. Wang,et al.  The effect of copper ion on arachidonic acid metabolism in the porcine corneal epithelium. , 1993, Biochemical and biophysical research communications.

[8]  D. Daret,et al.  Dual metabolic pathways of 12-HETE in rat aortic smooth muscle cells. , 1992, Prostaglandins.

[9]  H. Bazan,et al.  The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. , 1991, The Journal of biological chemistry.

[10]  H. Bazan,et al.  Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. , 1991, Experimental eye research.

[11]  M. Gerritsen,et al.  12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. , 1991, Experimental eye research.

[12]  M. Abelson,et al.  Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. , 1990, The American journal of pathology.

[13]  W. Powell,et al.  Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes. , 1990, Biochemistry.

[14]  J. Masferrer,et al.  Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid. , 1990, Biochemical pharmacology.

[15]  M. Abelson,et al.  Standard models of corneal injury using alkali-immersed filter discs. , 1989, Investigative ophthalmology & visual science.

[16]  F. Gonzalez,et al.  The molecular biology of cytochrome P450s. , 1988, Pharmacological reviews.

[17]  J. Masferrer,et al.  12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epithelium. , 1988, The Journal of biological chemistry.

[18]  J. Masferrer,et al.  Modulation of vascular tone by 12(R)-, but not 12(S)-, hydroxyeicosatetraenoic acid. , 1988, European journal of pharmacology.

[19]  M. Ingelman-Sundberg,et al.  Cytochrome P-450-dependent oxidase activity and hydroxyl radical production in micellar and membranous types of reconstituted systems. , 1988, Biochemical pharmacology.

[20]  H. Bazan,et al.  The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. , 1987, Biochemical and biophysical research communications.

[21]  J. Masferrer,et al.  12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Charleson,et al.  Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)- and (12S)-hydroxyeicosatetraenoic acid. , 1987, Biochimica et biophysica acta.

[23]  J. Falck,et al.  Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. , 1986, Biochemical and biophysical research communications.

[24]  J. Masferrer,et al.  Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. , 1985, Biochemical and biophysical research communications.

[25]  H. M. Wang,et al.  Latent and active plasminogen activator in corneal ulceration. , 1985, Investigative ophthalmology & visual science.

[26]  S. Murota,et al.  Age-related increase in the migration of aortic smooth muscle cells induced by 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid , 1984 .

[27]  H. Kuthan,et al.  Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system. , 1982, European journal of biochemistry.

[28]  V. Lakhanpal,et al.  Superoxide radical scavenging agents in treatment of alkali burns. An experimental study. , 1981, Archives of ophthalmology.

[29]  R. Pfister,et al.  The alkali burned cornea I. Epithelial and stromal repair. , 1976, Experimental eye research.

[30]  S. I. Brown,et al.  Alkali burns of the cornea. , 1969, Archives of ophthalmology.

[31]  M. Gerritsen,et al.  Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. , 1996, The American journal of pathology.

[32]  H. Shichi,et al.  Synthesis of 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by porcine ocular tissues. , 1994, Journal of ocular pharmacology.

[33]  M. Schwartzman,et al.  Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. , 1994, Journal of ocular pharmacology.

[34]  N. Abraham,et al.  Activation of Nuclear Factor KB and Oncogene Expression by 12(R)-Hydroxyeicosatrienoic Acid, an Angiogenic Factor in , 1994 .

[35]  H. Bazan,et al.  Inhibition of the alkali burn-induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet activating factor antagonist. , 1987, Journal of ocular pharmacology.

[36]  J. Masferrer,et al.  Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. , 1987, Current eye research.